LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Top Factors Driving Global POC Glucose Monitoring Devices Market

By LabMedica International staff writers
Posted on 23 Feb 2018
Image: The global market for POC blood glucose monitoring devices is expected to be driven mainly by public and private initiatives to reduce diabetic cases (Photo courtesy of Roche).
Image: The global market for POC blood glucose monitoring devices is expected to be driven mainly by public and private initiatives to reduce diabetic cases (Photo courtesy of Roche).
The global market for POC blood glucose monitoring devices is expected to grow at a CAGR of over 8% during the period 2018-2022, driven mainly by public and private initiatives to reduce diabetic cases. These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

There has been an increase in the incidence of lifestyle diseases such as diabetes, which is of three types: Type 1, Type 2, and gestational diabetes (diabetes during pregnancy). The CDC estimates that, as of 2017, more than 30 million individuals in the US had diabetes, out of which over 95% had Type 2 diabetes. Heredity, obesity, unhealthy diet, and sedentary lifestyle are the main factors responsible for Type 2 diabetes. The growing aged population and increasing number of overweight individuals is leading to a higher number of adults suffering from diabetes.

In order to prevent or delay Type 2 diabetes, the US government is introducing several programs under the national diabetes prevention program in association with the CDC, such as the CDC-recognized diabetes prevention lifestyle change program. The increase in such public and private initiatives to reduce the number of diabetic cases will have the highest positive impact on the growth of the POC blood glucose monitoring devices market.

Based on product, the global POC blood glucose monitoring devices market was dominated by the consumables segment in 2017 with the largest share of 67%. The largest share of the consumables segment was due to continuous usage of consumables while performing blood glucose monitoring tests, especially for diabetic patients. The growing preference for disposable consumables to reduce the risk of contamination is expected to further boost the demand for consumables among various healthcare centers. Based on end-user, the hospitals and clinics segment accounted for the largest share of the blood glucose monitoring devices market in 2017 due to the increasing number of diabetic cases in the US.

The POC blood glucose monitoring devices market is witnessing growth in the Americas due to increasing focus on advanced technologies and development of non-invasive wearable POC glucose monitoring devices. The market for blood glucose monitoring devices in the region will continue to grow during the period 2018-2022, driven by the availability of favorable reimbursements for POC blood glucose monitoring devices and increasing number of FDA approvals for technologically-advanced products. Additionally, the increasing cases of hyperglycemia will lead to an increase in the need for blood glucose tests and higher demand for POC blood glucose monitoring devices in the region over the next five years.

“The increasing diabetic patient pool also increases the economic burden due to which several public and private organizations around the world are engaged in activities to increase awareness and reduce the incidence of Type 2 diabetes which can be controlled or averted by adopting lifestyle changes. These awareness initiatives augur well for the growth of the market as they will encourage increased adoption of POC blood glucose monitoring devices,” said a senior analyst at Technavio.

Related Links:
Technavio Research

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more